WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Insights
Type
People
Practices
Industries
From Date
To Date
Reset Search

Search Results

Client Highlights

4.14.26

Wilson Sonsini Advises Atlas on $40 Million Series C
On April 14, 2026, Atlas, a first-of-its-kind, members-only concierge service and charge card focused on delivering access to coveted experiences through a seamless spending experience, announced its $40 million funding round, with a total valuation of $420 million. The funding round was led by solo venture capitalist Elad Gil and Verified Capital and included 01 Advisors, Marathon Management Partners, and others. Wilson Sonsini Goodrich & Rosati advised Atlas on the transaction.
Client Highlights

12.15.25

Wilson Sonsini Advises PolyAI on $86 Million Series D Financing
On December 15, 2025, PolyAI, a leader in enterprise conversational AI, announced it has raised $86 million in Series D funding, co-led by Georgian, Hedosophia, and Khosla Ventures. Additional investors include NVentures, British Business Bank, Citi Ventures, Squarepoint Ventures, Sands Capital, Zendesk Ventures, and Point72 Ventures. Wilson Sonsini Goodrich & Rosati advised PolyAI on the transaction.
Client Highlights

12.05.25

Wilson Sonsini Advises Chronosphere on $3.35 Billion Acquisition by Palo Alto Networks
On November 19, 2025, global cybersecurity leader Palo Alto Networks announced that it has entered into a definitive agreement to acquire Chronosphere, a next-generation observability platform built to scale for the AI era, for total consideration of $3.35 billion. Wilson Sonsini Goodrich & Rosati advised Chronosphere on the transaction.

The combination of Chronosphere and Palo Alto Networks’ AgentiX platform will deliver real-time, agentic remediation for the world’s leading AI-native companies and strengthen Palo Alto Networks' ability to help organizations navigate a world where modern applications and AI workloads demand a unified data and security foundation. The acquisition is subject to customary closing conditions, including regulatory approvals, and is expected to close in Palo Alto Networks’ second half of fiscal year 2026.

The Wilson Sonsini team that advised Chronosphere on the acquisition was led by Damien Weiss, Todd Cleary, Jack Hamilton, and Rob Broderick, and also included:
Client Highlights

2.04.25

Wilson Sonsini Advises TravelPerk on $200 Million Series E Financing
On January 28, 2025, TravelPerk, a business travel platform based in Barcelona, Spain, and Zurich, Switzerland, raised $200 million in Series E funding. The oversubscribed round doubled the company's valuation to $2.7 billion. The funding was led by Atomico and EQT Growth, with participation from Noteus Partners and existing investors, including Kinnevik and General Catalyst. TravelPerk was advised by Wilson Sonsini Goodrich & Rosati during the transaction.
Client Highlights

10.08.24

Wilson Sonsini Advises Maven Clinic on $125 Million Series F Financing
On October 8, 2024, Maven Clinic, a NYC-based virtual clinic for women’s and family health, announced it has raised $125 million in a Series F funding round. The round, which brought the total funding to more than $425 million, was led by StepStone Group, with participation from existing investors General Catalyst, Sequoia, Oak HC/FT, Icon Ventures, Dragoneer Investment Group, and Lux Capital. Wilson Sonsini Goodrich & Rosati represented Maven in the transaction.
Client Highlights

8.31.23

Wilson Sonsini Advises Gympass on $85 Million Series F Financing
On August 23, 2023, Gympass, a leading corporate wellness platform, announced it has raised $85 million in a Series F funding round, bringing the company's valuation to $2.4 billion. The round was led by EQT Growth, with participation from Neuberger Berman on behalf of its client funds. Wilson Sonsini Goodrich & Rosati represented Gympass in the transaction.
Client Highlights

11.29.22

Wilson Sonsini Advises Maven Clinic on $90 Million Series E
On November 14, 2022, Maven Clinic, one of the largest virtual clinics in women's and family health, announced that it raised a $90 million Series E funding round led by General Catalyst, with participation from CVS Health Ventures, La Famiglia, and Intermountain Ventures, as well as existing investors Sequoia, Oak HC/FT, Icon Ventures, Dragoneer Investment Group, and Lux Capital. This brings Maven's total funding to $300 million and highlights the growing demand for women's and family health services globally. Wilson Sonsini Goodrich & Rosati advised Maven Clinic on the transaction.
Client Highlights

1.12.22

Wilson Sonsini Advises Brex on $300 Million Series D-2 Financing
On January 11, 2022, Brex, the U.S. fintech company reimagining finance for growing businesses, announced it has raised an additional $300 million in a Series D-2 round led by Greenoaks Capital and Technology Crossover Ventures (TCV). The latest funding round will enable Brex to deepen its investment in expanding the company’s product portfolio, serving a wider range of finance needs for fast-growing companies. Since the company’s founding in 2017, Brex has raised a total of $1.2 billion from investors and is currently valued at $12.3 billion.
Client Highlights

8.18.21

Wilson Sonsini Advises Maven Clinic in $110 Million Series D
On August 17, 2021, Maven Clinic, the largest virtual clinic for women's and family health, announced it has closed $110 million in Series D funding. The funding round was co-led by Dragoneer Investment Group and Lux Capital, with participation from BOND and certain existing investors. Maven also welcomed Oprah Winfrey as an investor in the round. Wilson Sonsini Goodrich & Rosati represented Maven in the transaction.

The latest funding comes on the heels of a period of rapid growth for Maven. Since raising its Series C round of funding, Maven has significantly increased its client base across employers and payers, partnering with four new Fortune 15, with membership in Maven's employer and payer-sponsored programs increasing 400 percent. Even amidst this rapid growth, Maven has achieved a near 100 percent retention rate among existing clients like Boston Scientific, Booz Allen Hamilton, and L'Oreal.

Maven plans to use its Series D financing to expand into new populations and to invest in additional product innovation to further enhance its award-winning member experience designed to improve clinical outcomes.
Client Highlights

6.30.21

Wilson Sonsini Advises Gympass on $220 Million Series E
On June 29, 2021, Gympass, an exercise and corporate wellness unicorn that originated in Brazil, announced it has raised $220 million in a Series E financing. Wilson Sonsini Goodrich & Rosati represented Gympass in the transaction.
Client Highlights

4.22.21

Wilson Sonsini Advises KnowBe4 on Initial Public Offering
On April 21, 2021, KnowBe4, Inc., provider of the leading security awareness platform, announced the pricing of its initial public offering of 9,500,000 shares of its Class A common stock at a price to the public of $16.00 per share. KnowBe4 is offering 9,000,000 shares of its Class A common stock, and certain selling shareholders are offering 500,000 shares of KnowBe4’s Class A common stock. In addition, the underwriters have been granted a 30-day option to purchase up to an additional 1,425,000 shares of Class A common stock from KnowBe4 at the initial public offering price, less underwriting discounts and commissions. KnowBe4 will not receive any proceeds from any sales of shares by the selling stockholders. The shares began trading on the Nasdaq Global Select Market on April 22, 2021, under the symbol "KNBE." The offering is expected to close on April 26, 2021, subject to customary closing conditions. Wilson Sonsini Goodrich & Rosati is advising KnowB4 on the transaction.
Client Highlights

2.22.21

Firm Advises BlackSky Holdings in Merger with Osprey Technology Acquisition Corp.
On February 18, 2021, BlackSky Holdings, Inc., a real-time geospatial intelligence, imagery, and data analytics company, and Osprey Technology Acquisition Corp., a special purpose acquisition company, or SPAC, announced they entered into a definitive agreement for a business combination that would result in BlackSky becoming a publicly listed company. Wilson Sonsini Goodrich & Rosati is advising BlackSky in the transaction.
  • 1
  • 2
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.